Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Latanoprost, a glaucoma medication, caused excessive eyelid hair growth in many patients.

Upadacitinib effectively treats psoriasis and lichen planus together.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

GPR39 is linked to certain cells in the sebaceous gland and helps with skin healing.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

Tofacitinib might be used to treat hair loss.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

The new formulation improves dutasteride's absorption when taken orally.

Enhanced stem cells from the placenta can reduce fat buildup in eye tissue for Graves' disease.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

DHT stops hair regrowth in mice, similar to human hair loss.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Cyproterone Acetate effectively treats androgen-related conditions and is used in prostate cancer therapy and hormone therapy for transgender women.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

RSPO1 could help create new diabetes treatments by increasing pancreatic β cells.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Ginsenoside Rg1 protects mouse skin from UVB damage and helps control inflammation.

New LPA receptors (LPA4, LPA5, LPA6) have diverse roles in the body.

Epristeride's metabolism in zebrafish helps improve doping detection methods.